UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: april 2nd, 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based Enzyme‐Linked Immunosorbent Assays...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE
+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. SHOW MORE